Joseph Barsuglia is a research psychologist and a former Christian pastor. His mission is to create safe and sacred settings for providing holistic healing with psychedelic therapies and sacred earth medicines in order to address the modern crises of substance addiction, depression, and PTSD-related issues, as well as create centers with these therapies for human awakening and transformation.
Joseph is a research therapist in Los Angeles in the phase 3 trials of MDMA-Assisted Psychotherapy for PTSD sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He serves as an active board member and scientific advisor with two non-profit research groups, the Source Research Foundation (SRF) and Terra Incognita Project which are multidisciplinary groups focused on psychedelic research, mapping human consciousness, and conservation of sacred earth medicines.
He recently served as the Director of Clinical Research and Assessment and interim CEO at Crossroads Treatment Center in Mexico. This clinic was the first of its kind, a psychedelic treatment center, which utilized the psychedelic compounds Ibogaine and 5-MeO-DMT in the treatment of addiction and for psychospiritual development. In this role, Joseph collected and presented the first observational data on the effects of 5-MeO-DMT in humans, as well as the long-term outcomes of Ibogaine treatment in individuals with opioid use disorder.
Joseph earned a Master’s degree and PhD in clinical psychology with an emphasis in neuropsychology from the Fuller Graduate School of Psychology, and a Master’s degree in Spiritual Theology from the Fuller Theological Seminary. He received his clinical training in neuropsychology in several academic medical centers including the University of Southern California, the Semel Institute of Neuroscience at UCLA, and the West Los Angeles Veterans Hospital, where he completed an internship in aging/geriatric psychology.
He completed a postdoctoral research fellowship at the West Los Angeles Veterans Hospital in advanced geriatrics and behavioral neuroscience and his research is published in multiple peer-reviewed journals. Over the past 10 years, Joseph has focused primarily on aiding individuals with addictions, eating disorders, chronic mental illness, veterans’ issues, developmental trauma, and spiritual crisis. Joseph is committed to advancing research, clinical practice, and advocacy in the burgeoning field of psychedelic healthcare.